Head and Neck Neoplasm — Trials

Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06496178	A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)	active not recruiting	Phase 3	621	Merus B.V.INDUSTRY	24	Sep 25, 2026	clinicaltrials
NCT06525220	A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)	active not recruiting	Phase 3	699	Merus B.V.INDUSTRY	28	Sep 25, 2026